3
Announcements
Trials
Browse
Landscape
Status
Completed
4
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Neoplasms
6
Leukemia
3
Leukemia, Myeloid, Acute
2
Disease
2
Colorectal Neoplasms
2
Uveal Melanoma
1
Uterine Cervical Dysplasia
1
Sexually Transmitted Diseases
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Oropharyngeal Neoplasms
1
Myelodysplastic Syndromes
1
Motor Activity
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Infertility
1
Hypergammaglobulinemia
1
Hospitalism
1
Hematological Cancer
1
Hematologic Diseases
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Gestational Trophoblastic Tumours
1
Genetic Predisposition to Disease
1
Gastrointestinal Stromal Tumors
1
Exanthema
1
Dermatitis, Seborrheic
1
Depression
1
Interventions
Cyclophosphamide
37
Cytarabine
27
Methotrexate
22
Dexamethasone
20
Vincristine
19
fludarabine
15
Mercaptopurine
14
Etoposide
14
Radiotherapy
12
Daunorubicin
12
Asparaginase
12
Doxorubicin
11
Prednisolone
9
Idarubicin
9
Busulfan
8
pegaspargase
7
blinatumomab
7
Peripheral Blood Stem Cell Transplantation
6
Melphalan
6
Immunotherapy, Adoptive
6
Imatinib Mesylate
6
Dasatinib
6
fludarabine phosphate
5
Prednisone
5
Methylprednisolone
5
Filgrastim
5
Whole-Body Irradiation
4
Thioguanine
4
Rituximab
4
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Interviews as Topic
×
Clear all
NCT06107478
2023-10-30
MASSAYA
Centre Leon Berard
Unknown
181 enrolled